Non-cholinergic modulation of antisaccade performance: A modafinil-nicotine comparison

Psychopharmacology

Volumn 195, Issue 2, 2007, Pages 245-253

  Rycroft, N ^a   Hutton, S B ^a   Clowry, O ^a   Groomsbridge, C ^a   Sierakowski, A ^a   Rusted, J M ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

Cholinergic; Eye movement; Inhibition; Nicotine; Noradrenergic; Oculomotor; Saccade; Working memory

Indexed keywords

MODAFINIL; NICOTINE; PLACEBO;

ADULT; ARTICLE; ATTENTION; BEHAVIOR; BRAIN INJURY; CHOLINERGIC SYSTEM; CLINICAL TRIAL; COGNITION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN EXPERIMENT; INHIBITION (PSYCHOLOGY); LATENT PERIOD; MALE; MODULATION; NORMAL HUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; SACCADIC EYE MOVEMENT; SCHIZOPHRENIA; WORKING MEMORY;

ADULT; ANALYSIS OF VARIANCE; ATTENTION; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; DOUBLE-BLIND METHOD; HUMANS; MALE; MEMORY; NICOTINE; NICOTINIC AGONISTS; REACTION TIME; SACCADES; TASK PERFORMANCE AND ANALYSIS;

EID: 35748983788     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-007-0885-x     Document Type: Article

References (62)

1. Andersson K, Hockey GRJ (1977) Effects of cigarette smoking on incidental memory. Psychopharmacology 52:223-226
2. Baranski JV, Pigeau R, Dinich P, Jacobs I (2004) Effects of modafinil on cognitive and metacognitive performance. Hum Psychopharmacol 19:323-332
3. Ballon JS, Feifel D (2006) A systematic review of modafinil: Potential clinical uses and mechanisms of action. J Clin Psychiatry 67:554-566
4. Barrett SL, Bell R, Watson D, King DG (2004) Effects of amisulpride, risperidone and chlorpromazine on auditory and visual latent inhibition, prepulse inhibition, executive function and eye movements in healthy volunteers. J Psychopharmacol 18:156-172
5. Berridge CW, Waterhouse BF (2003) the locus coeruleus-noradrenergic system: modulation of behavioural state and state-dependent cognitive processes. Brains Res Rev 42:33-84
6. Caldwell JA Jr, Caldwell JL, Smythe NK III, Hall KK (2000) A double-blind, placebo controlled investigation of the efficacy of modafinil for sustaining the alertness and performance of aviators: a helicopter simulator study. Psychopharmacology 150:72-282
7. Chamberlain SR, Muller U, Blackwell AD, Robbins TW, Sahakian BJ (2006) Noradrenergic modulation of working memory and emotional memory in humans. Psychopharmacology 188:397-407
8. Chudasama Y, Robbins TW (2006) Functions of frontostriatal systems in cognition: comparative neuropsychological studies in rats, monkeys and humans. Biol Psychol 73:19-38
9. Clarke PBS, Reuben M (1996) Release of [3H]-noradrenalin from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release. Br J Pharmacol 117:595-606
10. Corrigall WA, Coen KM, Adamson L (1994) Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res 653:278-284
11. De Mey C, Enterling D, Meineke I (1993) Cardiovascular effects of eating, atenolol and their interaction: beta-1 adrenergic modulation does not play a predominant role in the genesis of postprandial effects. Br J Clin Pharmacol 36:427-435
12. De Séréville JE, Boer C, Rambert FA, Duteil J (1994) Lack of presynaptic dopaminergic involvement in modafinil activity in anesthetized mice-in-vivo voltammetry studies. Neuropharmacology 33:755-761
13. Depatie L, O'Driscoll GA, Holahan AV, Atkinson V, Thavundayil JX, Kin NNY, Lal S (2002) Nicotine and behavioural markers of risk for schizophrenia: a double-blind, placebo-controlled, cross-over study. Neuropsychopharmacology 27:1056-1070
14. Duka T, Lupp A (1997) The effects of incentive on antisaccades; is a dopaminergic mechanism involved? Behav Pharmacol 8:373-382
15. Dursun SM, Wright N, Reveley MA (1999) Effects of amphetamine on saccadic eye movements in man: possible relevance to schizophrenia? J Psychopharmacol 13:245-247
16. 1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; studies with experimental animals. Eur J Pharmacol 180:49-58
17. Dyckman KA, McDowell JE (2005) Behavioral plasticity of antisaccade performance following daily practice. Exp Brain Res 162:63-69
18. Engber TM, Dennis SA, Jones BE, Miller MS, Contreras PC (1998) Brain regional substrates for the actions of the novel wake-promoting agent modafinil in the rat: comparison with amphetamine. Neuroscience 87:905-911
19. Ettinger U, Kumari V, Crawford TJ, Davis RE, Sharma T, Corr PJ (2003) Reliability of smooth pursuit, fixation, and saccadic eye movements. Psychophysiology 40:620-628
20. 3 receptor. Neurosci Lett 220:5-8
21. Fischer B, Weber H (1992) Characteristics of "anti" saccades in man. Exp Brain Res 89:415-424
22. Foulds J, Stapleton J, Swettenham J, Bell N, McSorley K, Russell MAH (1996) Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers. Psychopharmacology 127:31-38
23. Gaymard B, Ploner CJ, Rivaud-Pechoux S, Pierrot-Deseilligny C (1999) The frontal eye field is involved in spatial short-term memory but not in reflexive saccade inhibition. Exp Brain Res 129:288-301
24. Green JF, King DJ, Trimble KM (2000) Antisaccade and smooth pursuit eye movements in healthy subjects receiving sertraline and lorazepam. J Psychopharmacol 14:30-36
25. Hallett PE (1978) Primary and secondary saccades to goals defined by instructions. Vis Res 18:1279-1296
26. Hermant JF, Rambert FA, Duteil J (1991) Awakening properties of modafinil-effect on nocturnal activity in monkeys (macaca-mulatta) after acute and repeated administration. Psychopharmacology 103:28-32
27. Hurt RD, Offord KP, Croghan IT, Crohgan GA, Gomez-Dahl LC, Wolter TD, Dale LC, Moyer TP (1998) Temporal effects of nicotine nasal spray and gum on nicotine withdrawal symptoms. Psychopharmacology 140:98-104
28. Hutton SB, Ettinger U (2006) The antisaccade task as a research tool in psychopathology: a critical review. Psychophysiology 43:302-313
29. Hutton SB, Crawford TJ, Puri BK, Duncan LJ, Chapman M, Kennard C, Barnes TR, Joyce EM (1998) Smooth pursuit and saccadic abnormalities in first-episode schizophrenia. Psychol Med 28:685-692
30. Hutton SB, Joyce EM, Barnes TRE, Kennard C (2002) Saccadic distractibility in first-episode schizophrenia. Neuropsychologia 40:1729-1736
31. James W (1890) The principles of psychology. Holt, New York
32. Jakala P, Riekkinen M, Sirvio J, Koivisto E, Riekkinen P (1999) Clonidine, but not guanfacine, impairs choice reaction time in young healthy volunteers. Neuropsychopharmacology 21:495-502
33. Khan SA, Ford K, Timney B, Everling S (2003) Effects of ethanol on anti-saccade task performance. Exp Brain Res 150:68-74
34. Knott VJ, Raegele M, Fisher D, Robertson N, Millar A, McIntosh J, Ilivitsky V (2005) Clonidine pre-treatment fails to block acute smoking-induced EEG arousal/mood in cigarette smokers. Pharmacol Biochem Behav 80:161-171
35. Kumari V, Postma P (2005) Nicotine use in schizophrenia: the self medication hypothesis. Neurosci Biobehav Rev 29:1021-1034
36. Larrison-Faucher AL, Briand KA, Sereno AB (2004a) Nicotine improves antisaccade task performance without affecting prosaccades. Human Psychopharmacol 19:409-419
37. Larrison-Faucher AL, Matorin AA, Sereno AB (2004b) Nicotine reduces antisaccade errors in task impaired subjects. Prog Neuro-psychopharmacol Biol Psychiatry 28:505-516
38. Lin JS, Roussel b, Akaoka H, Fort P, Debilly G, Jouvet M (1992) Role of catecholamines in modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat. Brain Res 591:319-326
39. Massen C (2004) Parallel programming of exogenous and endogenous components in the antisaccade task. Q J Exp Psychol 57A:475-498
40. McNair DM, Lorr M, Droppleman LF (1971) Manual for the Profile of Mood States. Educational and Industrial Testing Service, San Diego, CA
41. Moachon G, Kanmacher I, Clenet M, Matinier D (1996) Pharmacokinetic profile of modafinil. Med Actual 32:23-33
42. Müller U, Steffenhagen N, Regenthal R, Bublak P (2004) Effects of modafinil on working memory processes in humans. Psychopharmacology 177:161-169
43. Munoz DP, Everling S (2004) Look away: the antisaccade task and the voluntary control of eye movement. Nat Rev Neurosci 5:218-228
44. Norman DA (1981) Categorization of action slips. Psychol Rev 88:1-15
45. Pierrot-Deseilligny C, Muri RM, Nyffeler T, Milea D (2005) The role of the human dorsolateral prefrontal cortex in ocular motor behavior. Ann NY Acad Sci 1039:232-238
46. Powell J, Dawkins L, Davis RE (2002) Smoking, reward responsiveness and response inhibition: tests of an incentive motivational model. Biol Psychiatry 51:151-163
47. Rambert FA, Pessonnier J, Duteil J (1990) Modafinilphenidate, amphetaminephenidate and methylphenidate-induced hyperactivities in mice involve different mechanisms. Eur J Pharmacol 183:455-456
48. Randall DC, Fleck NL, Shneerson JM, File SE (2004) The cognitive-enhancing properties of modafinil are limited in non-sleep deprived middle-aged volunteers. Pharmacol Biochem Behav 77:547-555
49. Randall DC, Viswanath A, Bharania P, Elsabagh SM, Hartley DE, Shneerson JM, File SE (2005) Does modafinil enhance cognitive performance in young volunteers who are not sleep-deprived? J Clin Psychopharmacol 25:175-179
50. Reason J (1984) The psychopathology of everyday slips-accidents happen when habit goes haywire. Sciences (New York) 24:44-49
51. Robbins TW (2002) The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology 163:362-380
52. Rycroft N, Rusted JM, Hutton SB (2006) The antisaccade task as an index of sustained goal activation in working memory: modulation by nicotine. Psychopharmacology 188:521-529
53. Sarter M, Hasselmoe ME, Bruno JP, Givens B (2005) Unravelling the attentional functions of cortical cholinergic inputs: interactions between signal-driven and cognitive modulation of signal detection. Brains Res Rev 48:98-111
54. Scammell TE, Estabrooke IV, McCarthy MT, Chemelli RM, Yanagisawa M, Miller MS, Saper CB (2000) Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci 20:8620-8628
55. Smyrnis N, Evdokimidis I, Stefanis NC, Constantinidis TS, Avramopoulos D, Theleritis C, Paximadis C, Efstratiadis C, Kastrinakis G, Stefanis CN (2002) The antisaccade task in a sample of 2,006 young males. II Effects of task parameters. Exp Brain Res 147:53-63
56. Stivalet P, Esquivie D, Barraud PA, Leifflen D, Raphel C (1998) Effects of modafinil on attentional processes during 60 hours of sleep deprivation. Hum Psychopharmacol 13:501-507
57. Turner DC, Robbins TW, Clark L, Aron AR, Dowson J, Sahakian BJ (2003) Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology 165:260-269
58. Watkins SS, Stinus L, Koob GF, Markou A (2000) Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects. J Pharmacol Exp Ther 292:1053-1064
59. Wesensten NJ, Belenky G, Kautz MA, Thorne DR, Reichardt RM, Balkin TJ (2002) Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine. Psychopharmacology 159:238-247
60. Williams GV, Goldman-Rakic PS (1995) Modulation of memory fields by dopamine D1 recpetors in prefrontal cortex. Nature 376:572-575
61. Wisor JP, Eriksson KS (2005) Dopaminergic-adrenergic interactions in the wake promoting mechanism of modafinil. Neuroscience 132:1027-1034
62. Wong YN, King P, Laughton WB, McCormick GC, Grebow PE (1998) Single-dose pharmacokinetics of modafinil and methylphenidate given alone or in combination in healthy male volunteers. J Clin Psychopharmacol 38:276-282